#breaking The HIV treatment combining #islatravir and #lenacapavir achieved its primary efficacy endpoint in two phase 3 trials, bringing the investigational regimen closer to becoming the first approved long-acting oral #HIV therapy. #IDsky
www.contagionlive.com/view/once-we...
www.contagionlive.com
A once-weekly oral HIV treatment combining islatravir and lenacapavir achieved its primary efficacy endpoint in two Phase 3 trials, bringing the investigational regimen closer to becoming the first ap...
